1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A48BBD6B8F4798C365257D4100207013
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-success-factors-and-failure-points-in-oncology-product-launches?opendocument
18
19opendocument
203.90.12.112
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services Product Launch Market Entry and Oncology

White Paper: Success Factors and Failure Points in Oncology Product Launches

Whitepaper Image

ID: BEB-57


Pages/Slides: 7


Published: 2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Please click on "Buy Now" to obtain the white paper on “Success Factors and Failure Points in Oncology Product Launches.”

Having a successful product launch in the complex oncology market is quite a challenging task for marketers. In order to resolve some of the uncertainties associated with oncology product launches, companies need to develop a strategy that will best differentiate their products and draw on insights from thought leaders in the industry.

This white paper delivers qualitative and quantitative insights into new product launch successes and failures. Select key findings in the white paper include the most influential factors in determining pricing against competitors and the minimum level of superior efficacy required to charge more than a branded competitor.

If you would like to purchase the full study this summary is based on
click here.

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies